Objectives: To describe and assess, via simulation, a constraint-based spline approach to implement smooth hazard ratio (HR) waning in time-to-event analyses.
Methods: A common consideration when extrapolating survival functions to evaluate the long-term performance of a novel intervention is scenarios where the beneficial effect of an intervention eventually disappears (treatment effect waning). One approach to relaxing the proportional hazards assumption for a treatment effect is to model it as a function of the timescale, with a spline function offering a flexible approach. We consider the constraint of coefficients of spline variables to 0 during estimation, leading to log-treatment effects that are constrained to 0 (HR = 1) from a given time-point: enforcing treatment efficacy waning. An example is reported. Datasets were simulated under a variety of scenarios and analyzed with treatment effect waning assumptions under various modeling choices. Bias in mean survival time difference, given fully observed waning or fully censored waning, was assessed and constrained HR estimates were visualized.
Results: Given full waning, biases were small unless constraints directly contradicted truths. When waning was extrapolated, akin to real-life practice, biases over observed periods were minimized through the inclusion of a knot at the 95th percentile. The rate at which the HR waned slowed as the upper boundary knot/constraint was placed later, inducing less conservative treatment effect waning assumptions.
Conclusion: An alternative approach to modeling smooth treatment efficacy waning is demonstrated, enabling HR conditioning and marginal RMST calculation in a single framework, along with applications of the method beyond this use.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891414 | PMC |
http://dx.doi.org/10.1002/sim.70035 | DOI Listing |
Reprod Biomed Online
November 2024
IVIRMA Global Research Alliance, IVIRMA Madrid, Spain; Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain, and Rey Juan Carlos University, Madrid, Spain.
With a growing number of women in developed countries having children later in life, it is time to rethink women's reproductive health. This trend of 'delayed parenthood' reflects a complex interplay of labour market rules, personal choices, rarefying social connections and the renowned possibilities of assisted reproductive technology (ART). While ART offers support, its success wanes with age, prompting a rise in additional strategies such as elective ovarian cryopreservation.
View Article and Find Full Text PDFJ Headache Pain
March 2025
Japanese Red Cross Society Shizuoka Hospital, Shizuoka, Japan.
Background: Real-world data on the long-term adherence to- and efficacy of fremanezumab 675 mg quarterly dosing remain scarce. Our study evaluated the efficacy of- and patient adherence to 675 mg fremanezumab for episodic migraine (EM) and chronic migraine (CM) over 2 years and analyzed the reasons for discontinuation.
Methods: Among patients attending our headache outpatient clinic, those aged ≥ 15 years who commenced fremanezumab 675 mg quarterly dose schedule from November 2021 to June 2022 were enrolled in this single-center observational study.
Cholera is a diarrheal disease that continues to burden vulnerable populations globally, primarily due to lack of clean water, optimal sanitation and adequate health infrastructure. Understanding the kinetics of antibody responses elicited by toxigenic infection can inform the Sero-epidemiological estimation of disease burden and impact of vaccination efforts. While antibody kinetics have been well-described in South Asia, such studies based in Africa are lacking, despite the ongoing prevalence of cholera in that region.
View Article and Find Full Text PDFStat Med
March 2025
Biostatistics Research Group, Department of Population Health Sciences, University of Leicester, Leicester, UK.
Objectives: To describe and assess, via simulation, a constraint-based spline approach to implement smooth hazard ratio (HR) waning in time-to-event analyses.
Methods: A common consideration when extrapolating survival functions to evaluate the long-term performance of a novel intervention is scenarios where the beneficial effect of an intervention eventually disappears (treatment effect waning). One approach to relaxing the proportional hazards assumption for a treatment effect is to model it as a function of the timescale, with a spline function offering a flexible approach.
Expert Rev Vaccines
December 2025
Department of Pediatrics, Kumar Child Clinic, Dwarka, India.
Introduction: Typhoid fever is widespread in developing countries. Most typhoid vaccines have gone into some disrepute for their substantial side effects and low efficacy. The latest typhoid vaccines use Vi-capsular polysaccharide (Vi-CPS) conjugated to a protein carrier.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!